Abstract
Renal cell carcinoma is a heterogenous cancer composed of an increasing number of unique subtypes each with their own cellular and tumor behavior. The study of hereditary renal cell carcinoma, which composes just 5% of all types of tumor cases, has allowed for the elucidation of subtype-specific tumorigenesis mechanisms that can also be applied to their sporadic counterparts. This review will focus on the major forms of hereditary renal cell carcinoma and the genetic alterations contributing to their tumorigenesis, including von Hippel Lindau syndrome, Hereditary Papillary Renal Cell Carcinoma, Succinate Dehydrogenase-Deficient Renal Cell Carcinoma, Hereditary Leiomyomatosis and Renal Cell Carcinoma, BRCA Associated Protein 1 Tumor Predisposition Syndrome, Tuberous Sclerosis, Birt–Hogg–Dubé Syndrome and Translocation RCC. The mechanisms for tumorigenesis described in this review are beginning to be exploited via the utilization of novel targets to treat renal cell carcinoma in a subtype-specific fashion.
Funder
National Institutes of Health
Subject
Genetics (clinical),Genetics
Reference240 articles.
1. Models of Renal Cell Carcinoma Used to Investigate Molecular Mechanisms and Develop New Therapeutics;Front. Oncol.,2022
2. Renal cell carcinoma: An overview of the epidemiology, diagnosis, and treatment;G. Ital. Nefrol.,2022
3. Trichloroethylene Is Associated with Kidney Cancer Mortality: A Population-based Analysis;Anticancer Res.,2015
4. Arsenic in drinking water and renal cancers in rural Bangladesh;Occup. Environ. Med.,2013
5. Environmental and modifiable risk factors in renal cell carcinoma;Urol. Oncol.,2012
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献